Evidence map›Paper›PMID 39148892›Full record

ArticleBiofilm2024

Yael Schlichter Kadosh, Subramani Muthuraman, Khairun Nisaa, Anat Ben-Zvi, Danit Lisa Karsagi Byron, Marilou Shagan, Alexander Brandis, Tevie Mehlman, Jacob Gopas, Rajendran Saravana Kumar and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biofilm, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Anti-QS Strategies AgainstMicroorganisms · 2025
    Review
  6. NF-Journal of immunology research · 2025
    Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yael Schlichter KadoshAvram and Stella Goldstein-Goren Department of Biotechnology Engineering, Ben Gurion University of the Negev, Beer Sheva, Israel.
Subramani MuthuramanChemistry Division, Vellore Institute of Technology, Chennai, India.
Khairun NisaaDepartment of Life Science, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Anat Ben-ZviDepartment of Life Science, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Danit Lisa Karsagi ByronDepartment of Civil and Environmental Engineering, Ben-Gurion University of the Negev, Beer Sheva, Israel.
Marilou ShaganAvram and Stella Goldstein-Goren Department of Biotechnology Engineering, Ben Gurion University of the Negev, Beer Sheva, Israel.
Alexander BrandisDepartment of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
Tevie MehlmanDepartment of Life Sciences Core Facilities, Weizmann Institute of Science, Rehovot, Israel.
Jacob GopasDepartment of Microbiology, Immunology and Genetics Faculty of Health Sciences, Ben Gurion University of the Negev, Beer Sheva, Israel.
Rajendran Saravana KumarChemistry Division, Vellore Institute of Technology, Chennai, India.
Ariel KushmaroAvram and Stella Goldstein-Goren Department of Biotechnology Engineering, Ben Gurion University of the Negev, Beer Sheva, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial communication, Quorum Sensing (QS), is a target against virulence and prevention of antibiotic-resistant infections. 16 derivatives of Piperlongumine (PL), an amide alkaloid from

Indexed as

Amide alkaloidBacterial biofilmIron acquisitionPiper longumPiperlonguminePseudomonas aeruginosaQuorum sensingTranscriptome

Identifiers

PMID39148892
PMCPMC11326495

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.